熱門資訊> 正文
BioTE报告第二季度GAAP每股收益为-0.19美元
2024-08-09 20:22
- Biotech Acquisition Co Ordinary Shares - Class A(BIOT) 0
- Biote Corp. - Class A Common Stock(BTMD) 0
- iShares LifePath Target Date 2025 ETF USD(ITDA) 0
- BIOTE press release (NASDAQ:BTMD): Q2 GAAP EPS of -$0.19.
- Revenue of $49.2 million.
- Procedure revenue of $38.4 million.
- Gross profit margin of 68.9%, including a $1.2 million inventory step-up related to the acquisition of Asteria Health.
- Adjusted EBITDA for the second quarter of 2024 was $12.7 million, with an Adjusted EBITDA margin of 25.9%.
More on BIOTE
- Seeking Alpha’s Quant Rating on BIOTE
- Historical earnings data for BIOTE
- Financial information for BIOTE
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
